News Summary: Alzheimer drug may slow brain plaque

MORE DISAPPOINTMENT: Two major studies of an experimental Alzheimer’s drug show it doesn’t stop mental decline, the latest setback in finding a treatment for the mind-robbing disease.

HOPEFUL SIGN: There was a hint that the drug bapineuzumab, made by Pfizer Inc. and Johnson & Johnson, might help if given sooner, before the disease has caused too much damage and memory loss.

WHAT’S NEXT: Tests in patients with mild mental impairment or those with brain plaque who haven’t yet developed disease symptoms. More results on this drug and a similar one by Eli Lilly & Co. are expected next month.

© Copyright Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Also in this section

7 poisoned in Czech Republic by bootleg liquor

PRAGUE (AP) — At least four more people have died in the Czech Republic after …

Premiums for family health plans hit $15,745

WASHINGTON (AP) — Annual premiums for job-based family health insurance went up just 4 percent …

NFL awarding $1.5 million in medical grants

NEW YORK (AP) — NFL Charities is awarding more than $1.5 million in grants for …